Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-046847
Filing Date
2024-11-19
Accepted
2024-11-19 16:57:33
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1256796
2 ex10-1.htm EX-10.1 12488
3 ex10-2.htm EX-10.2 37417
4 ex31-1.htm EX-31.1 12399
5 ex31-2.htm EX-31.2 12441
6 ex32-1.htm EX-32.1 7824
7 ex32-2.htm EX-32.2 7869
  Complete submission text file 0001493152-24-046847.txt   5829368

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE sigy-20240930.xsd EX-101.SCH 39134
9 XBRL CALCULATION FILE sigy-20240930_cal.xml EX-101.CAL 45596
10 XBRL DEFINITION FILE sigy-20240930_def.xml EX-101.DEF 135555
11 XBRL LABEL FILE sigy-20240930_lab.xml EX-101.LAB 353279
12 XBRL PRESENTATION FILE sigy-20240930_pre.xml EX-101.PRE 272437
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 931843
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

EIN.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55575 | Film No.: 241477026
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)